Key result
Biomarker-based pathway stratifies cardiovascular risk and guides treatment for postoperative myocardial injury after non-cardiac surgery.
Why the study?
Perioperative morbidity and mortality remain substantial problems linked to cardiac comorbidities, and newer guidelines are increasingly incorporating cardiac biomarkers into cardiovascular risk assessment for non-cardiac surgery.
Cardiac biomarkers are increasingly incorporated into guidelines for preoperative risk stratification in non-cardiac surgery to predict adverse cardiac events.
Perioperative morbidity and mortality remains a substantial problem and is strongly associated with patients' cardiac comorbidities. Guidelines for the cardiovascular assessment and management of patients at risk of cardiac issues while undergoing non-cardiac surgery are traditionally based on the exclusion of active or unstable cardiac conditions, determination of the risk of surgery, the functional capacity of the patient, and the presence of cardiac risk factors. In the last two decades, strong evidence showed an association between cardiac biomarkers and adverse cardiac events, with newer guidelines incorporating this knowledge. This review describes a biomarker-based risk-stratification pathway and discusses potential treatment strategies for patients suffering from postoperative myocardial injury or infarction.
No takes yet. Share an insight, caveat, or question.
Yurttas et al. (2020) conducted a review in Patients undergoing non-cardiac surgery at risk of cardiac issues. Biomarker-based risk-stratification pathway was evaluated. A biomarker-based risk-stratification pathway is described to assess cardiovascular risk and guide treatment for patients with postoperative myocardial injury after non-cardiac surgery.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: